Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Neurovascular coupling in patients with relapsing-remitting multiple sclerosis.
Sema4A inhibits the therapeutic effect of IFN-β in EAE.
UCSF Seminar: "MRI of Lesion Development and Repair in Multiple Sclerosis"
Keystone Symposium on the Gut Microbiome: The Effector/Regulatory Immune Network
EMD Serono and Pfizer announce FDA approval of Rebif® Rebidose® (interferon beta-1a)
New TECFIDERA® (dimethyl fumarate) data show sustained efficacy and long-term safety in a broad range of multiple sclerosis patients
Sphingosine-1-Phosphate (S1P) Impacts Presynaptic Functions by Regulating Synapsin I Localization in the Presynaptic Compartment.
Hypovitaminosis D upscales B-cell immunoreactivity in multiple sclerosis.
Rituximab for relapsing-remitting multiple sclerosis.
TECFIDERA® (Dimethyl Fumarate) Data Reinforce Strong, Sustained Efficacy for Newly-Diagnosed MS Patients
Tract-specific and age-related variations of the spinal cord microstructure: a multi-parametric MRI study using diffusion tensor imaging (DTI) and inhomogeneous magnetization transfer (ihMT).
Pre-specified subgroup analyses of a placebo-controlled phase III trial (TEMSO) of oral teriflunomide in relapsing multiple sclerosis.
Tizanidine: Can Buy Uk
Interferon-beta1b for the treatment of multiple sclerosis.
Inhibition of LTi Cell Development by CD25 Blockade Is Associated with Decreased Intrathecal Inflammation in Multiple Sclerosis.
Drugs@FDA
Clinical Significance of Gastrointestinal and Flushing Events in Patients with Multiple Sclerosis Treated with Delayed-Release Dimethyl Fumarate.
Neuromyelitis optica spectrum disorders: Comparison according to the phenotype and serostatus.
Compromised axon initial segment integrity in EAE is preceded by microglial reactivity and contact.
Central nervous system neuroinflammatory disorders in Asian/Pacific regions.
UCSF Seminar: "Imaging spinal cord gray matter atrophy in MS using SF-SIGMA. Is neuronal loss a key mediator of MS disability?"
Implications of Real-world Adherence on Cost-effectiveness Analysis in Multiple Sclerosis.
Immunology of Multiple Sclerosis.
Developing a Valuation Function for the Preference-Based Multiple Sclerosis Index: Comparison of Standard Gamble and Rating Scale.
The Effects of IFN-β 1a on the Expression of Inflammasomes and Apoptosis-Associated Speck-Like Proteins in Multiple Sclerosis Patients.

Pages